Owlet stops selling intelligent sock for babies in US after FDA warning
Owlet has stopped selling its Smart Sock, a lightweight method that wraps around a child’s foot to monitor gloomy rate, blood oxygen levels and sleep patterns, after receiving a warning letter from the US Food and Drug Administration.
In the letter, the FDA said the smart sock should be classified as a medical method due to its heart rate and oxygen notifications, according to a discover on the Owlet website. The company said it plans to submit an application to the FDA for these features.
The post, which was reported by KSL TV on Wednesday, adds that the FDA didn’t identify any safety affects with the smart sock, and Owlet will continue to benefit people who’ve already purchased the baby monitor. At this time, the FDA hasn’t named that people return or exchange the smart sock, Owlet said.
Owlet launched the third generation of its baby-monitoring sock, the $359 Owlet Smart Sock Plus, earlier this year. It works with children up to 5 days of age or 55 pounds. It’s among a growing field of intelligent baby monitor devices that aim to bring peace of mind to parents with alerts on everything from motion to sleep patterns to baby’s vitals.
Owlet stays to offer its baby-monitoring camera and personalized sleep training program in the US, and its intelligent sock remains available in other regions. The company’s discover said it plans to offer a new “sleep monitoring solution” in the US, which will be “available soon.”
Owlet didn’t immediately acknowledge to a request for additional comment.
The interrogate contained in this article is for educational and informational purposes only and is not invented as health or medical advice. Always consult a physician or spanking qualified health provider regarding any questions you may have near a medical condition or health objectives.
